IEL Science Signs Agreement with LaMeditech to Develop Laser Devices Using Silicone Lens Technology

IL Science, a specialized company in smart optical solutions, announced on the 26th that it has signed a memorandum of understanding (MOU) with laser-based healthcare company LaMeditech to develop ‘laser-based beauty and healthcare devices utilizing silicon lens technology.’

Song Seong-geun (left), CEO of IL Science, and Choi Jong-seok, CEO of La Meditech. Photo by IL Science

Through this agreement, IL Science will supply specialized new technology silicon lenses by applying near-infrared quality (IR grade) and microlens array (MLA) lenses to the laser devices developed by LaMeditech. LaMeditech plans to develop beauty and healthcare devices leveraging ultra-compact laser technology.

The silicon lens technology, developed for the first time in the world by IL Science, offers superior performance and characteristics compared to glass or plastic materials, with the notable feature of not requiring mold manufacturing processes. It is lighter due to its lower density compared to conventional lenses and has heat resistance and high elasticity. With a transmittance rate of over 96%, it minimizes energy loss.

LaMeditech, leading with the world’s first ultra-compact laser technology, is developing technologies capable of treating beauty, atopic dermatitis, dementia, and cancer in collaboration with the world’s largest global companies. Their ultra-compact laser technology enhances skin beauty and drug absorption by ten times compared to existing methods, and in partnership with the world’s largest global companies, they are developing drug delivery systems that maximize effects from skin beauty and atopic dermatitis treatment to dementia and cancer therapy.

As demand for beauty procedures increases domestically and internationally, the introduction of invasive beauty medical devices is rising, rapidly growing the related market. According to market research firm Mordor Intelligence, the global beauty medical device market is expected to grow from 36 trillion KRW this year at an average annual rate of 10%, reaching 59 trillion KRW by 2029.

Song Seong-geun, CEO of IL Science, stated, “Collaboration with laser device specialist LaMeditech will be an opportunity for the technology of our self-developed silicon lenses to rapidly expand into the healthcare field,” adding, “Considering the excellent performance and characteristics of silicon lenses, they will expand not only in the healthcare market but also into various industrial sectors.”

This content was produced with the assistance of AI translation services.